BUSINESS ARCHITECTURE MODEL (BAM)
The Business Architecture Model is part of the Clinical Trials Management Systems (CTMS) Workspace.
The Translational Research in Medicine Business Architecture Model (BAM) is designed to describe the activities, goals, and people involved in biomedical research, including clinical trials, laboratory research, and the organizational needs required to support these activities. The model will include diagrams and descriptions (often called process maps that make up an overall model) that show how biomedical research is generally done. For example, initial process maps for clinical research include developing an initial clinical study plan, conducting the clinical study with patients, and then writing up the results of that study. Process maps in the area of life sciences (which include biospecimen management and genomic research) are also in early development.
Ultimately, the process maps will include a broad scope of biomedical research activities being done by a large range of organizations, including the National Cancer Institute, Cooperative Groups, Cancer Centers, Community Clinical Oncology Programs (CCOP), and other governmental and private entities.Read more in our Overview Fact Sheet about the Business Architecture Model (BAM)
How Can I Help?
The BAM team needs help from clinical specialists, research subject matter experts, and patient advocate representatives to continue to develop, validate, deepen, and expand the different process elements of the draft model developed to date.
Here are some first steps:
Release BAM v 2.1 Content
The caBIG® Translational Research in Medicine Business Architecture Model Release 2.1 is available in an html representation, a report document, and a package file that includes the release notes, Enterprise Architect file, and xmi file.
For additional information, previous releases and updates visit the BAM wiki.